Jazz Pharmaceuticals and AbCellera have announced a significant preclinical research, option, and license agreement, poised to accelerate the discovery and…
Read More
FDA Approves Four Groundbreaking Cancer Drugs in May, Offering New Hope for Hematological and Solid Tumors
The U.S. Food and Drug Administration (FDA) has authorized four significant new cancer drugs in May 2026, marking a pivotal…
Read More
Navigating the Evolving Landscape of Oral Solid Dosage Development: A Framework for Enhanced Efficiency and Commercial Success
The pharmaceutical industry is witnessing a significant evolution in oral solid dosage (OSD) development, driven by an increasing demand for…
Read More
Bristol Myers Squibb and Oxford BioTherapeutics Forge Alliance to Pioneer Novel T-Cell Engager Therapies for Solid Tumors
Bristol Myers Squibb (BMS) and Oxford BioTherapeutics (OBT) have announced a significant strategic alliance aimed at discovering and developing a…
Read More
Machine Learning Integration with Raman Spectroscopy Accelerates the Discovery of High-Performance Superionic Conductors for Solid-State Batteries
The global transition toward sustainable energy and the electrification of transportation has placed an unprecedented demand on battery technology, leading…
Read More
